Company Filing History:
Years Active: 2017-2022
Title: The Innovative Insights of Inventor Paola Leone
Introduction
Paola Leone, an accomplished inventor located in Cherry Hill, NJ, has made significant contributions to the field of neuroscience through her innovative research and inventions. With a total of three patents, her latest work focuses on addressing oxidative stress in the brain, a condition that affects numerous individuals and requires novel treatment strategies.
Latest Patents
One of Paola Leone's latest patents is titled "Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid." This groundbreaking invention presents a novel method for treating brain disorders that exhibit oxidative stress. Leone's method enhances the ability of targeted neuron populations to catabolize the acetylated amino acid derivative, N-acetylaspartic acid (NAA). By utilizing the targeted expression of the NAA catabolic enzyme aspartoacylase (ASPA) in neurons and astrocytes, the invention aims to supply extraphysiological levels of ATP to neurons, potentially transforming the treatment landscape for affected individuals.
Career Highlights
Paola's career at Rowan University has been marked by her dedication to innovative research and her commitment to advancing understanding in the realm of brain disorders. Her continued work has garnered attention within the academic and medical communities, establishing her as a key figure in the field.
Collaborations
Throughout her career, Paola Leone has collaborated with fellow researchers, including Jeremy Francis. These collaborations have fostered an environment of innovation and have played a crucial role in the development of her patents and research projects.
Conclusion
Paola Leone's work exemplifies the spirit of innovation and dedication to improving health outcomes for individuals with brain disorders. With her patented inventions and ongoing research at Rowan University, she continues to contribute valuable insights to the scientific community, paving the way for future advancements in metabolic therapy and neuroscience.